•
Dec 31, 2011

Arrowhead Pharmaceuticals Q1 2012 Earnings Report

Total Revenue
$4.02M
Previous year: $4.99M
-19.6%
EPS
-$0.25
Previous year: -$0.2
+24.8%
Gross Profit
-$71.6M
Previous year: $4.99M
-1533.3%
Cash and Equivalents
$6.77M
Total Assets
$23.1M

Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals